Saturday, 11 April 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
FDA Grants Priority Review for Takeda (TAK) and Protagonist’s Rusfertide in PV Treatment
8 Mar, 16:01 — 8 Mar, 16:01
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
34d ago
FDA Grants Priority Review for Takeda (TAK) and Protagonist’s Rusfertide in PV Treatment
Read full article →
Something wrong with this story? Report an issue
Related Stories
Iloilo Reinstates Health Protocols Amid Extreme Heat
just now
Four arrested for selling P102 million in fake anti-cancer medicines in Makati
just now
Vigilance Urged After Death of Two Children in Abandoned Car
just now
Calapan City heat index hits dangerous 44°C
just now
Saturday, 11 April 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
